Cadrenal Therapeutics CVKD Growth Metrics (2022-2026)

NASDAQ CVKD
$1.60 +0.00 (+0.00%)
As of: Aug 21, 2026 · 12:40 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) (Quarter) 994.77%57.26%53.33%-49.75%18.83%12.84%9.55%-12.64%-57.26%-64.01%-6.51%
Assets Growth (3y) (Quarter) 77.16%-13.89%16.23%
Assets (QoQ) (Quarter) 475.97%-20.59%161.63%-8.51%-17.26%-22.58%-14.25%116.35%-21.44%-24.83%-31.63%5.85%-33.85%95.28%
Cash & Equivalents Growth (1y) (Quarter) 25,685.61%63.00%55.96%-52.09%19.23%11.72%10.59%-11.55%-59.99%-68.65%-57.14%
Cash & Equivalents Growth (3y) (Quarter) 397.31%-17.04%-9.42%
Cash & Equivalents (QoQ) (Quarter) 12,262.26%-19.82%182.04%-7.76%-21.85%-23.29%-13.37%129.56%-26.77%-24.06%-30.71%3.83%-42.61%3.98%
Cash from Operations Growth (1y) (Quarter) -3,133.01%-75.51%-50.29%-139.29%-29.98%-92.28%-250.64%-157.86%-153.15%-97.86%-7.08%-43.52%35.47%26.20%
Cash from Operations Growth (3y) (Quarter) -373.83%-88.31%-78.03%-106.89%-28.53%-41.08%
Cash from Operations (QoQ) (Quarter) -936.97%7.82%30.52%-386.81%43.71%21.07%-10.62%-164.44%16.73%-43.94%18.65%-159.60%34.91%22.10%-9.03%-16.73%25.62%
EBIT Growth (1y) (Quarter) -2,363.18%-112.75%-17.46%-17.46%58.20%-140.37%-115.30%-51.39%10.55%
EBIT Growth (3y) (Quarter) -97.83%-48.20%
EBIT (QoQ) (Quarter) -182.87%-101.68%-10.61%-290.37%75.57%-11.34%-10.61%-38.91%-40.50%0.27%
EBT Growth (1y) (Quarter) -2,801.90%-309.27%-80.12%-4.57%66.78%-20.07%-53.94%-60.63%13.64%
EBT Growth (3y) (Quarter) -99.11%-18.54%
EBT (QoQ) (Quarter) -183.19%-101.79%-10.92%-357.81%60.06%11.19%35.60%-45.42%-44.37%-13.86%
Enterprise Value Growth (1y) (Quarter) -25,685.61%-63.00%-55.96%52.09%-19.23%-11.72%-10.59%11.55%59.99%68.65%57.14%
Enterprise Value Growth (3y) (Quarter) -397.31%17.04%9.42%
Enterprise Value (QoQ) (Quarter) -12,262.26%19.82%-182.04%7.76%21.85%23.29%13.37%-129.56%26.77%24.06%30.71%-3.83%42.61%-3.98%
EPS (Basic) Growth (1y) (Quarter) -1,920.35%-169.53%5.97%89.33%77.65%12.08%-43.13%16.93%38.99%
EPS (Basic) Growth (3y) (Quarter) -25.33%23.62%
EPS (Basic) (QoQ) (Quarter) -175.12%-93.82%-547.67%41.50%63.30%32.38%26.51%-22.56%-44.37%-10.07%
EPS (Diluted) Growth (1y) (Quarter) -1,920.35%-169.53%5.97%38.85%77.65%12.08%-43.13%16.93%38.99%
EPS (Diluted) Growth (3y) (Quarter) -25.33%23.62%
EPS (Diluted) (QoQ) (Quarter) -175.12%-93.82%-12.99%-235.33%63.30%32.38%26.51%-22.56%-44.37%-10.07%
Free Cash Flow Growth (1y) (Quarter) -3,133.01%-75.51%-50.29%-139.28%-29.98%-92.28%-250.64%-157.86%-153.32%-97.86%-7.17%-43.52%35.51%26.20%
Free Cash Flow Growth (3y) (Quarter) -373.94%-88.31%-78.08%-106.89%-28.53%-41.08%
Free Cash Flow (QoQ) (Quarter) -936.97%7.82%30.52%-386.81%43.71%21.06%-10.62%-164.44%16.73%-43.94%18.65%-159.79%34.96%22.04%-8.94%-16.73%25.62%
Interest Coverage Ratio Growth (1y) (Quarter) 93.66%98.63%97.85%-74,008.92%-26,755.82%-387.30%92.92%-1,720.85%
Interest Coverage Ratio Growth (3y) (Quarter) 36.05%-602.27%
Interest Coverage Ratio (QoQ) (Quarter) 8.68%4.02%17.25%91.26%80.20%-50.06%92.82%97.28%
Net Cash Flow Growth (1y) (Quarter) 764.25%-97.50%12,761.79%-902.82%-145.95%-92.28%-111.45%900.71%-46.06%-15.44%-154.08%-97.39%36.71%104.45%
Net Cash Flow Growth (3y) (Quarter) -98.32%-63.66%-240.34%59.99%-34.35%28.03%
Net Cash Flow (QoQ) (Quarter) -187.10%111.35%-254.21%5,768.10%-119.90%839.29%-112.02%-159.72%16.71%55.97%940.75%-147.38%34.17%3.10%108.63%-1,249.19%104.62%
Net Income Growth (1y) (Quarter) -2,801.90%-309.27%-80.12%-4.57%66.78%-20.07%-53.94%-60.63%13.64%
Net Income Growth (3y) (Quarter) -99.11%-18.54%
Net Income (QoQ) (Quarter) -183.19%-101.79%-10.92%-357.81%60.06%11.19%35.60%-45.42%-44.37%-13.86%
Net Income towards Common Stockholders Growth (1y) (Quarter) -2,801.90%-309.27%-80.12%-4.57%66.78%-20.07%-53.94%-52.68%9.40%
Net Income towards Common Stockholders Growth (3y) (Quarter) -95.77%-18.43%
Net Income towards Common Stockholders (QoQ) (Quarter) -183.19%-101.79%-10.92%-357.81%60.06%11.19%35.60%-45.42%-44.37%-13.86%
Operating Income Growth (1y) (Quarter) -2,363.18%-112.75%-17.46%-17.46%58.20%-140.37%-115.30%-51.39%10.55%
Operating Income Growth (3y) (Quarter) -97.83%-48.20%
Operating Income (QoQ) (Quarter) -182.87%-101.68%-10.61%-290.37%75.57%-11.34%-10.61%-38.91%-40.50%0.27%
Profit After Tax Growth (1y) (Quarter) -2,828.75%-99.74%-1.01%77.16%67.85%-138.58%-132.31%-53.25%9.40%
Profit After Tax Growth (3y) (Quarter) -94.02%-49.07%
Profit After Tax (QoQ) (Quarter) -184.26%-104.35%-388.19%-3.28%80.61%-3.33%-10.38%-45.38%-43.87%-0.62%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) 125.77%105.35%-64.94%-71.78%203.63%176.80%250.57%603.81%-25.49%-1.26%-37.46%
Property, Plant & Equipment (Net) Growth (3y) (Quarter) 72.22%77.71%-8.40%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -18.76%322.84%-17.13%-20.70%-26.10%-27.81%-33.28%753.07%-32.63%-8.57%33.95%-9.69%-10.73%-42.09%
Return on Assets Growth (1y) (Quarter) 2.001.000.000.000.001.001.000.00-1.000.00
Return on Assets Growth (3y) (Quarter) 4.003.00
Return on Assets (QoQ) (Quarter) 1.001.000.000.000.000.001.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) 22,717.006,108.00-8224.00-5860.00-24284.00
Return on Capital Employed Growth (3y) (Quarter) -24036.00
Return on Capital Employed (QoQ) (Quarter) 10,253.007,273.003,243.001,947.00-6355.00-7059.00
Share-based Compensation Growth (1y) (Quarter) -77.05%-43.18%15.09%97.69%741.40%237.22%153.29%1,331.62%-47.16%282.68%136.23%
Share-based Compensation Growth (3y) (Quarter) 0.67%94.28%102.82%
Share-based Compensation (QoQ) (Quarter) -36.27%-41.41%-41.04%4.23%57.82%18.67%1.28%343.60%-36.75%-10.86%472.43%-83.63%358.04%-33.33%